Microbot Medical Inc.
Close on Oct 19, 2026
- Market cap
- $63.99M
- P/E (TTM)
- –
- Dividend yield
- –
About Microbot Medical
Surgical & Medical Instruments & Apparatus, SIC 3841
Microbot Medical Inc. is a medical device company that researches, designs, and develops robotic endoluminal surgical systems. The company focuses on developing its proprietary robotic surgical platform, known as the LIBERTY Endovascular Robotic Surgical System, which is designed for use in endovascular procedures. Microbot aims to serve healthcare providers, medical facilities, and surgical specialists conducting minimally invasive interventions.
The company operates facilities in Israel, where it conducts research, development, and operational activities, and maintains its principal executive offices in Hingham, Massachusetts. Microbot Medical Ltd. functions as its wholly owned operational subsidiary in Israel.
Summary of the business section of Microbot Medical's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Microbot Medical Inc.
- Headquarters
- Hingham, MA
- Address
- 25 Recreation Park Dr Suite 108 02043
- Phone
- (908) 938-5561
- Website
- microbotmedical.com
- Employees
- 43, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Brightman Almagor Zohar & Co., Tel Aviv, Israel
Stock & identifiers
- Ticker
- MBOT
- Exchange
- Nasdaq
- IPO date
- Mar 25, 1992
- Shares outstanding
- 67M, Aug 11, 2026
- Public float
- $95.66M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-14.75 reverse, Nov 14, 2018; 1-for-15 reverse, Sep 5, 2018; 1-for-9 reverse, Nov 29, 2016; 1-for-12 reverse, May 9, 2016; 1-for-12 reverse, Dec 31, 2015; 1-for-10 reverse, Jul 6, 2011
- SEC CIK
- 883975
- CUSIP
- 59503A204
- ISIN
- US59503A2042
- LEI
- 549300AEUNO16KTJXD72
- EIN
- 94-3078125
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Harel Gadot | Chairman, President and CEO, Director | 136,847 |
| Simon Sharon | General Manager, CTO | – |
| Rachel Vaknin | Chief Financial Officer | – |
| Juan Diaz-Cartelle | Chief Medical Officer | – |
| Tal Baruch Wenderow | Director | – |
| Scott R. Burell | Director | – |
| David James Wilson | Director | – |
| Martin J. Madden | Director | – |
| Prattipati Laxminarain | Director | – |
| Aileen Ptucha Stockburger | Director | – |
Employees
Headcount reported in annual reports
“As of March 24, 2026, we have 43 employees (including full-time and hourly employees).”
Corporate history
Events identified from SEC filings